ASM Global’s Coca-Cola Music Hall Celebrates First Anniversary as One of World’s Fastest-growing Venues
15.9.2022 03:22:00 EEST | Business Wire | Press release
This week marks the one-year milestone of the debut of one of live entertainment’s most technologically advanced venues that has enjoyed record-breaking attendance and along with it world ranking in box office sales.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220811005250/en/
Within only five months of operation, Coca-Cola Music Hall closed 2021 as one of the leaders in box office sales worldwide for theaters. Photo courtesy: ASM Global
To date, Coca-Cola Music Hall has held 59 concerts and 43 private events with a total attendance of more than 165,000 people.
ASM Global President and CEO Ron Bension said, “Our work with Coca-Cola Music Hall is an excellent example that the island is ready to foster more significant alliances of private and government companies for the development of all sectors.”
Since its opening, the 4,200 capacity Coca-Cola Music Hall has featured artists such as: Ednita Nazario, Caramelos de Cianuro, El Gran Combo de Puerto Rico, Stryper, Jesse & Joy, Louis Tomlinson, Gente de Zona, Toño Rosario, Ana Torroja, Camilo, Ilé, Alejandro Fernández, CNCO, Jerry Rivera, Manuel Turizo, Eladio Carrión, Noel Schajris, DJ Nelson & Alberto Stylee, Melendi, Rosario, Nío García, RKM & Ken-Y, Il Divo, Los Tres Pianistas, Myriam Hernández, Almost Queen, and Barak, among others.
It was also the venue for the Miss World 2021 International Pageant and comedy shows from Daniel “El Travieso” and “Sé lo tuyo!” with Alexandra Fuentes and Raymond Arrieta.
The three-level theater—one of the industry’s first to be cashless—features the most advanced sound system of any venue its size in the world and the most advanced fixed lighting system in Puerto Rico. Coca-Cola Music Hall quickly assembled a large team of in-house specialists to help clients with staging, audio-visual and acoustic services, all of which are included as part of the rental fee. Other amenities include ultramodern suites, dressing rooms, Wi-Fi coverage, box office, security, ushers and cleaning, among other services.
“On behalf of the entire Coca-Cola Music Hall team, we thank the public for the support we have received in just one year. We have managed to keep the entertainment industry in Puerto Rico thriving. We showed the world that we are a world-class venue, and I am confident that we will continue to grow in the years to come,” said Jorge L. Perez, ASM Global regional manager in Puerto Rico.
Thanks to its strategic location within DISTRITO T-Mobile, visitors to the Coca-Cola Music Hall can enjoy great experiences before and after each event. The experiential complex comprises several areas, including Popular Plaza, which is an open space with state-of-the-art LED screens, restaurants, a 177-room Aloft San Juan Hotel, Caribbean Cinemas VIP, Toro Verde Urban Park with ziplines and much more.
“Coca-Cola Music Hall is a state-of-the-art performance hall that competes with the best international venues and offers locals and visitors a one-of-a-kind experience. The diversity and capabilities of its facilities and the public’s response have been key to both the venue and DISTRITO T-Mobile’s success as the premier entertainment destination in Puerto Rico,” said Francisco Mariani, general manager of DISTRITO T-Mobile.
The executive director of the Puerto Rico Convention Center District Authority, Mrs. Mariela Vallines, added, “The Convention District has an ambitious plan to continue improving our facilities and expand the entertainment offered for our visitors. All our facilities have proven to be ideal for any private and public event. This first anniversary of the Coca-Cola Music Hall echoes that we are doing the right thing so that Puerto Rico continues to develop both in the entertainment industry as well as tourism, gastronomy and other related sectors.”
Within only five months of operation, the Coca-Cola Music Hall closed 2021 in the No. 31 position in box office sales worldwide (theater category) in Pollstar magazine’s “Year-End” results.
“We are extremely grateful to the artists and the producers for choosing Coca-Cola Music Hall as the ideal place to host their events and also to our partner PRISA Group and sponsors: Coca-Cola, T-Mobile, Banco Popular de Puerto Rico, JetBlue, Visa, Evertec, Cervecera de Puerto Rico, Destileria Serralles, V. Suarez and ticketing partner Ticketera. We are committed in continuing to offer a varied entertainment program in a safe environment. This is an achievement for all of Puerto Rico,” said Perez.
The public can be part of this grand celebration; Coca-Cola Music Hall will hold several contests. Those interested can participate as often as they want and must register at www.cocacolamusichallexperience.com. Among the prizes you could win are a weekend stay at the Aloft San Juan Hotel located in DISTRITO T-Mobile, product gift baskets and much more.
Upcoming events to be held at Coca-Cola Music Hall include:
|
2022 |
||
|
August 12 |
Coca-Cola Music Fest |
|
|
August 13 |
Coca-Cola Music Fest |
|
|
August 20 |
Natalia Jimenez |
|
|
August 21 |
Natalia Jimenez |
|
|
August 28 |
Yesenia Then |
|
|
September 2 |
Vicente Garcia |
|
|
September 3 |
Lilly Goodman |
|
|
September 9 |
Servando and Florentino |
|
|
September 17 |
Yolandita Monge |
|
|
October 1 |
Shine Fest |
|
|
October 6, 7 & 9 |
Mora |
|
|
October 8 |
Firehouse & Winger |
|
|
October 21 |
Fiel a La Vega |
|
|
October 28 |
La Secta All Stars |
|
|
October 29 |
Limit-T 21 |
|
|
November 5 |
Jorge Drexler |
|
|
November 6 |
Raphael |
|
|
November 11 |
Bomba Estereo |
|
|
November 12 |
Sebastian Yatra |
|
|
November 20 |
Miel San Marcos |
|
|
November 23 |
Pablo Alboran |
|
|
|
|
|
|
2023 |
||
|
March 4 |
Milly Quezada |
|
|
May 13 |
Maicol & Manuel |
About ASM Global
ASM Global is the world’s leading producer of entertainment experiences. It is the global leader in venue and event strategy and management—delivering locally tailored solutions and cutting-edge technologies to achieve maximum results for venue owners. The company’s elite venue network spans five continents, with a portfolio of more than 350 of the world’s most prestigious arenas, stadiums, convention and exhibition centers, and performing arts venues. Follow us on Facebook, Instagram, LinkedIn and Twitter. asmglobal.com
For more information on the Coca-Cola Music Hall, visit:
https://www.cocacolamusichall.com/
https://www.facebook.com/cocacolamusichall/
https://www.instagram.com/cocacolamh/
https://twitter.com/CocaColaMH
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220811005250/en/
Contact information
Media Contact:
Jim Yeager
breakwhitelight (for ASM Global)
jim@breakwhitelight.com
Mobile: 818-264-6812
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 11:00:00 EEST | Press release
OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 18:15:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 13:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202613.6.2026 00:31:00 EEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 19:36:00 EEST | Press release
IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
